Início › Leucemia Bifenotípica Aguda › Nova York › New York City
Ensaios clínicos de Leucemia Bifenotípica Aguda em New York City, NY
10 estudos para Leucemia Bifenotípica Aguda estão buscando participantes em locais em New York City e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
RecrutandoFase 1
- Memorial Sloan Kettering Cancer Center, New York
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RecrutandoFase 2
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
RecrutandoFase 1/2
- Montefiore Medical Center, New York
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RecrutandoFase 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Mount Sinai Hospital, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- e mais 2
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecrutandoFase 1/2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
RecrutandoFase 1
- Memorial Sloan- Kettering Cancer Center, New York
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
RecrutandoFase 2
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
A Study of Revumenib and Mezigdomide in People With Leukemia
RecrutandoFase 1/2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
RecrutandoFase 1
- Memorial Sloan Kettering Cancer Center, New York
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RecrutandoFase 1
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
Ensaios de Leucemia Bifenotípica Aguda em outras cidades
- Seattle, WA15 estudos
- Houston, TX11 estudos
- Atlanta, GA9 estudos
- Durham, NC8 estudos
- Memphis, TN7 estudos
- Chicago, IL7 estudos
- Charlotte, NC6 estudos
- Baldwin Park, CA6 estudos
- Philadelphia, PA6 estudos
- Dallas, TX6 estudos
- Aurora, CO6 estudos
- Portland, OR6 estudos
Outros estudos em New York City
- Câncer de Mama136 estudos
- Câncer de Pulmão de Não Pequenas Células121 estudos
- Câncer (todos os tipos)109 estudos
- Câncer de Próstata103 estudos
- Câncer Metastático93 estudos
- Câncer Colorretal78 estudos
- Câncer de Ovário69 estudos
- Câncer de Pulmão60 estudos
- Mieloma Múltiplo60 estudos
- Câncer de Pâncreas60 estudos
- Câncer Endometrial52 estudos
- Leucemia Mieloide Aguda51 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.